Post Profile






UAB Drug Study First Effort to Prevent Onset of Epilepsy in Tuberous Sclerosis Complex

Researchers at UAB have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
read more

share

Related Posts


New Study Compares Different Approaches for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation

Health : Newswise Medical News

UAB doctors say stroke prevention treatments are not one-size-fits-all, and treatment options can be individualized using this hierarchical ranking.

Drug shrinks brain tumors in children with tuberous sclerosis complex

Academics / General Science : Science Codex

A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC) -- a genetic disease that cause...

Drug reduces seizure frequency in children with tuberous sclerosis complex

Academics / General Science : Science Codex

In an international study, the drug everolimus has been shown to significantly reduce the frequency of seizures in patients with treatment-resistant epilepsy and tuberous sclerosis complex (TSC) -- a genetic disease that causes malf...

Drug Shows Dramatic Reduction in Seizures In Patients with Tuberous Sclerosis Complex

Health : Newswise Medical News

A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce seizures in patients with tuberous sclerosis complex (TSC) - a genetic disease characterized by benign tumors on m...

Drug Shows Dramatic Reduction In Seizures In Patients With Tuberous Sclerosis Complex

Health : Medical News Today

Further Studies Could Determine Benefit to Epilepsy Patients Without TSC A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce seizures in patients with tuberous sclero...

Comments


Copyright © 2016 Regator, LLC